| |
| |
|
| Insider
Information: |
Boyd Thomas A |
| Relationship: |
Sr. VP, Product Dev. |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
47,137 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$193,262 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
47,137 |
|
|
| Total
Value |
$193,262 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
Sr. VP, Product Dev. |
2010-07-01 |
47,137 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
Sr VP, Product DevelopmentOffi |
• – – |
2005-06-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,176 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2005-10-03 |
4 |
D |
$24.67 |
$7,154 |
D/D |
(290) |
20,329 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
officerTitle |
• – – |
2006-01-03 |
4 |
D |
$25.84 |
$8,372 |
D/D |
(324) |
20,430 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2006-04-03 |
4 |
D |
$25.61 |
$8,733 |
D/D |
(341) |
20,505 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2005-10-03 |
4 |
OE |
$16.81 |
$6,018 |
D/D |
358 |
20,619 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
officerTitle |
• – – |
2006-01-03 |
4 |
OE |
$20.86 |
$7,656 |
D/D |
367 |
20,754 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2006-04-03 |
4 |
OE |
$21.77 |
$8,185 |
D/D |
376 |
20,846 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-01-03 |
4 |
D |
$26.66 |
$10,184 |
D/D |
(382) |
33,625 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2006-10-02 |
4 |
D |
$23.03 |
$9,857 |
D/D |
(428) |
23,579 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-01-03 |
4 |
OE |
$21.88 |
$9,365 |
D/D |
428 |
34,007 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2006-10-02 |
4 |
OE |
$19.58 |
$9,203 |
D/D |
470 |
23,960 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-07-02 |
4 |
D |
$22.01 |
$10,917 |
D/D |
(496) |
36,209 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2006-12-15 |
4/A |
AS |
$26.05 |
$13,025 |
D/D |
(500) |
33,579 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2006-12-15 |
4/A |
OE |
$13.63 |
$6,813 |
D/D |
500 |
34,079 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-07-02 |
4 |
OE |
$18.71 |
$10,197 |
D/D |
545 |
36,705 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2008-01-02 |
4 |
D |
$18.03 |
$11,359 |
D/D |
(630) |
36,564 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2008-01-02 |
4 |
OE |
$15.33 |
$10,608 |
D/D |
692 |
37,194 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
SR. VP, Product Development |
• – – |
2005-06-20 |
4 |
S |
$19.85 |
$14,888 |
D/D |
(750) |
12,426 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2009-01-02 |
4 |
D |
$10.74 |
$13,242 |
D/D |
(1,233) |
38,340 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2009-01-02 |
4 |
OE |
$9.13 |
$12,371 |
D/D |
1,355 |
39,573 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2008-04-01 |
4 |
D |
$7.67 |
$13,361 |
D/D |
(1,742) |
31,905 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2006-07-03 |
4 |
D |
$24.26 |
$43,644 |
D/D |
(1,799) |
16,990 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-04-02 |
4 |
D |
$24.10 |
$43,838 |
D/D |
(1,819) |
33,926 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2007-10-01 |
4 |
D |
$22.39 |
$41,354 |
D/D |
(1,847) |
36,441 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Product Dev. |
• – – |
2008-04-01 |
4 |
OE |
$6.52 |
$12,479 |
D/D |
1,914 |
33,647 |
0 |
- |
|
76 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
